‘The science labs of the future?’ Human scientists oversee robots : NPR

‘The science labs of the future?’ Human scientists oversee robots : NPR

‘The science labs of the future?’ Human scientists oversee robots : NPR

https://www.npr.org/2026/06/05/nx-s1-5846973/ai-science-robots-risks-experiments-gingko-bioworks

Publish Date: 2026-06-05 05:00:00

Source Domain: www.npr.org

Here is a summary of the article with between 4 and 8 key points:

  • Founding Philosophy: Four MIT graduate students believed that programming cells could be more important than programming computers, and they founded Ginkgo Bioworks to automate laboratory tasks that used to require human labor.

  • AI Revolution: Initially struggling to attract investors, Ginkgo Bioworks started gaining traction after the AI boom in 2014 when Sam Altman’s blog post highlighted the potential to automate biotechnology.

  • Autonomous Lab: The company now operates an autonomous lab using robotics and AI to conduct experiments in pharmaceuticals, agriculture, and government projects.

  • Robotic Execution: Robots perform tedious lab tasks such as mixing chemicals and operating with petri dishes while AI translates experimental designs into detailed instructions for these robots.

  • AI-Driven Experimentation: Ginkgo Bioworks experimented with AI from OpenAI to let the robot itself devise and execute part of the experimentation process, achieving cost reductions and significant cost efficiency.

  • Future Implications: There are concerns about democratizing science, potentially leading to biosecurity threats and misuses since AI now opens these scientific practices to untrained people, whereas traditionally this work required extensive expertise.

  • Statements from Founders: Both Reshma Shetty and Jason Kelly acknowledge the role of AI in revolutionizing their scientific practices but stress that human oversight remains critical.

  • Ethical Concerns: Experts like Drew Endy emphasize the need for regulations and policies to mitigate the risks associated with AI in biotechnology, including potential bioweapons development by others.